2,3,7,8-tetrachlorodibenzodioxine has been researched along with pci 32765 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caspers, N; Douhan, J; Dunussi-Joannopoulos, K; Han, S; Hegen, M; Keegan, S; Kim, KH; Kurumbail, R; Li, E; Lin, L; Lussier, J; Maderna, A; Miyashiro, J; Mohan, S; Nickerson-Nutter, CL; Schnute, ME; Soutter, H; Wissner, A; Wittwer, AJ; Wrocklage, C | 1 |
1 other study(ies) available for 2,3,7,8-tetrachlorodibenzodioxine and pci 32765
Article | Year |
---|---|
Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis.
Topics: Agammaglobulinaemia Tyrosine Kinase; Arthritis, Rheumatoid; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinoxalines | 2011 |